Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company
Tickers CEO
Tags Retail industry Consumer Finance Brand acquisitions
From CNBC.com News
Here are 20 stocks I'm watching Tuesday, including Lilly, AMD and Goldman Sachs
Tags CNBC Investing Club: Newsletter Novo Nordisk A/S Broadcom Inc
From CNBC.com News
Weight loss drugs may be linked to stomach paralysis, other rare but severe issues, study says
Tags US: News Pharmaceuticals Health care industry
From CNBC.com News
Here are 18 stocks I am watching in the market, including Clorox, Rivian and Airbnb
Tags Marathon Petroleum Corp Booking Holdings Inc Jack in the Box Inc
From CNBC.com News
Drugmakers opt in to Medicare drug price negotiations – here's what happens next
Tags AstraZeneca PLC Breaking news Novartis AG
From CNBC.com News
Big Food vs. Big Pharma: Companies bet on snacking just as weight loss drugs boom
Tags Retail industry Hershey Co Kellogg Co
From CNBC.com News
Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill data
Tags Companies Health & Science Health care industry
From CNBC.com News
Ad spending for obesity, diabetes drugs is soaring this year, as drugmakers shell out nearly $500 million
Tags Health care industry Companies Health & Science
From CNBC.com News
Ozempic, Wegovy drug prescriptions hit 9 million, surge 300% in under three years
Tags Pharmaceuticals US: News Eli Lilly and Co
From CNBC.com News
Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug
Tags Business News Biotechnology Business
From CNBC.com News
Here's why Jim Cramer likes J.M. Smucker's plan to buy the maker of Twinkies
Tags CNBC Investing Club: Newsletter Food and drink Mergers
From CNBC.com News
Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here's what we know
Tags Business News Science Novo Nordisk A/S
From CNBC.com News
Big pharma's blockbuster obesity drug battle is just getting started, and it's headed for $100 billion
Tags Novo Nordisk A/S Technology Pfizer Inc
From CNBC.com News
Blockbuster weight loss drugs Wegovy and Ozempic are being tested to treat addiction and dementia
Tags Biotech and Pharmaceuticals Eli Lilly and Co Pharmaceuticals
From CNBC.com News
Stocks making the biggest moves premarket: Enbridge, Roku, Gitlab and more
Tags Roku Inc Zscaler Inc Dominion Energy Inc
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug launches in the UK
Tags Aviva PLC Pharmaceuticals Europe News
From CNBC.com News
Weight loss drugmaker Novo Nordisk vies to become Europe's most valuable company, toppling LVMH
Tags Europe Markets Business Novo Nordisk A/S
From CNBC.com News
5 things to know before the stock market opens Friday
Tags Dell Technologies Inc Tilray Brands Inc Novo Nordisk A/S
From CNBC.com News
Ozempic could be the next target of Medicare drug price negotiations – here's why
Tags Social issues Biotech and Pharmaceuticals Breaking news
From CNBC.com News
Wegovy helps reduce heart failure symptoms in obese people, study says
Tags Health & Science Companies Health care industry
From CNBC.com News
Weight loss drugs boost sales at retail pharmacies, but they may not help profits much
Tags Health care industry Companies Kroger Co
From CNBC.com News
Weight loss drugs are priced substantially higher in the U.S. than in other countries, analysis says
Tags Business Biotechnology Novo Nordisk A/S
From CNBC.com News
Wegovy could prevent up to 1.5 million heart attacks, strokes over 10 years, study says
Tags Science Novo Nordisk A/S Heart attack
From CNBC.com News
Novo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billion
Tags Health care industry Health & Science Companies
From CNBC.com News
Wegovy-maker Novo Nordisk sales soar 30% on strong demand for its weight-loss drug
Tags Novo Nordisk A/S Earnings Europe Markets
From CNBC.com News
Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data
Tags Diabetes Health & Science Eli Lilly and Co
From CNBC.com News
Obesity drug Wegovy's landmark trial result could 'open up' health insurance access, analyst says
Tags Europe News Asia News LVMH Moet Hennessy Louis Vuitton SE
From CNBC.com News
Stocks making the biggest moves midday: Beyond Meat, Chegg, PNC Financial, Dish & more
Tags Novo Nordisk A/S Markets stocks
From CNBC.com News
Stocks making the biggest moves premarket: UPS, Lucid, Beyond Meat, Novo Nordisk and more
Tags Business Citizens Financial Group Inc Goldman Sachs Group Inc
From CNBC.com News
Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials
Tags Health care industry Companies Health & Science
From CNBC.com News
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.